Company Monitoring Page for Vivus

latest headlines for company on cafepharma

8 Potential Biotech Acquisition Candidates
Seeking Alpha
Mon, 06/20/11 - 09:30 am
Tags:
biotech, M&A, Arena Pharmaceuticals, Biomarin, Dendreon, Human Genome Sciences, Keryx, MannKind, Novartis, Orexigen, Vivus
3 Ways to Play Biotech With Options
Motley Fool
Tue, 06/14/11 - 08:05 pm
Tags:
Amarin, SIGA technologies, Acorda Therapeutics, Orexigen, Vivus
FDA Bullies Obesity Drugmakers
Motley Fool
Sat, 06/4/11 - 10:06 am
Tags:
Orexigen, Contrave, Vivus, Qnexa, Arena Pharmaceuticals, obesity, weight loss
Arena's New Data Doesn't Change Obesity Pill Outlook
Investopedia
Mon, 05/30/11 - 06:39 pm
Tags:
obesity, Arena Pharmaceuticals, Human Genome Sciences, Dendreon, Orexigen, Vivus, Vanda
Arena, Orexigen and Vivus: An Update on Their Obesity Drugs
Seeking Alpha
Sat, 05/28/11 - 12:00 pm
Tags:
Arena Pharmaceuticals, Orexigen, Vivus, obesity, Qnexa, weight loss, Contrave
Vivus readies NDA as Ph3 trial hits goals for ED drug
Fierce Biotech
Wed, 05/25/11 - 11:39 am
Tags:
Vivus, erectile dysfunction, Avanafil
Diet-drug makers move into spotlight
MarketWatch
Sat, 05/21/11 - 10:44 am
Tags:
Arena Pharmaceuticals, Vivus, Albany Molecular Research
Epilepsy Drug Study Showing Little Risk May Help Vivus Pill
Bloomberg
Tue, 05/17/11 - 08:53 pm
Tags:
Vivus, epilepsy, Qnexa
Vivus Still Looking for Ways to Push Diet Drug Forward
Seeking Alpha
Mon, 05/9/11 - 09:19 am
Tags:
Vivus, obesity, Qnexa
Vivus Puts Obesity Drug On A Diet
TheStreet.com
Tue, 05/3/11 - 09:02 am
Tags:
Vivus, obesity, Qnexa
Vivus halves first-quarter loss
Bizjournals.com
Tue, 05/3/11 - 07:15 am
Tags:
earnings, Vivus
What Vivus Fails To Say About Its Diet Pill Study
Pharmalot
Tue, 04/12/11 - 10:06 am
Tags:
Vivus, Qnexa, obesity
Qnexa Trial Data is Good News for Vivus as Stock Rises
WSJ Online
Mon, 04/11/11 - 11:42 am
Tags:
Qnexa, Vivus, obesity
Vivus shares Qnexa study data
Yahoo/AP
Mon, 04/4/11 - 09:29 am
Tags:
obesity, Vivus, Qnexa
Vivus Shares Fall 13 Percent After FDA Topamax Risk Warning
Bloomberg
Fri, 03/4/11 - 10:40 am
Tags:
Vivus, birth defects, Topamax, JNJ, Qnexa
Analyst Notes: Vivus delivers Qnexa update
Yahoo/AP
Tue, 03/1/11 - 11:33 am
Tags:
Vivus, obesity, Qnexa
FDA Setbacks Make Vivus a Buying Opportunity
Seeking Alpha
Wed, 02/23/11 - 08:02 am
Tags:
FDA, Vivus, Qnexa, obesity
Obesity Drugs: The Road to Perdition
TheStreet.com
Tue, 02/1/11 - 11:22 am
Tags:
obesity, Orexigen, Vivus, Arena Pharmaceuticals, Contrave, Qnexa, Lorqess
5 Drugmakers Headed Back to the Drawing Board
Motley Fool
Mon, 01/31/11 - 06:54 pm
Tags:
Bydureon, Eli Lilly, Amylin, diabetes, MannKind, Afrezza, InterMune, Esbriet, IPF, Lorqess, Arena Pharmaceuticals, Vivus, Qnexa
A Foursome Of Pharma Earnings Suggests Business Is Still Tough
Investopedia
Mon, 01/31/11 - 05:07 pm
Tags:
earnings, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, MannKind, Novartis, Vivus

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.